Sign in
DWTX Stock Price, Chart, Stats & News
Dogwood Therapeutics, Inc.
Save
Dogwood Therapeutics, Inc. (DWTX) does not currently pay a dividend.
45.74M
Market cap
–
Current P/E
–
Forward P/E
DWTX chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.50% |
ROA | -41.53% |
ROE | -66.07% |
D/E | 0.00x |
Interest coverage ratio | -104.80x |
DWTX valuation
P/E | – |
P/S | – |
P/B | 0.05x |
P/CF | -0.21x |
P/FCF | -0.21x |
P/OCF | -0.21x |
PEG | 0.00x |
EV multiple | -0.43x |
About
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia.
Similar securities
Based on sector and market capitalization
Report issue